scholarly article | Q13442814 |
P819 | ADS bibcode | 2008PLoSO...3.3230R |
P356 | DOI | 10.1371/JOURNAL.PONE.0003230 |
P932 | PMC publication ID | 2535567 |
P698 | PubMed publication ID | 18800172 |
P5875 | ResearchGate publication ID | 23264838 |
P50 | author | Amancio Carnero | Q56468043 |
Irene Ferrer | Q57415858 | ||
Juan F M Leal | Q57966866 | ||
Lidia Ruiz | Q57975534 | ||
P2093 | author name string | Magali Traskine | |
Estrella Castro | |||
Marcelline Kaufman | |||
P2860 | cites work | Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling | Q22003910 |
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras | Q22254666 | ||
p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 | Q24290402 | ||
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a | Q24324559 | ||
A biomarker that identifies senescent human cells in culture and in aging skin in vivo | Q24562644 | ||
Protein phosphatase 1alpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis | Q24594034 | ||
p53-independent functions of the p19(ARF) tumor suppressor | Q24600863 | ||
A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization | Q24669694 | ||
p53, the cellular gatekeeper for growth and division | Q27860990 | ||
Atmospheric carbon dioxide concentrations over the past 60 million years | Q28144787 | ||
Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers | Q28237942 | ||
Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity | Q28594156 | ||
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors | Q29614399 | ||
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence | Q29620428 | ||
The retinoblastoma tumor-suppressor gene, the exception that proves the rule | Q33562001 | ||
The cellular response to p53: the decision between life and death | Q33771774 | ||
Regulation and function of the p53-related proteins: same family, different rules | Q33885465 | ||
Tumor suppressors and oncogenes in cellular senescence. | Q33930350 | ||
Oncogenic ras and p53 cooperate to induce cellular senescence | Q34279104 | ||
PPP1CA contributes to the senescence program induced by oncogenic Ras. | Q53325013 | ||
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. | Q53505779 | ||
The senescent side of tumor suppression | Q53648671 | ||
Suppressing cancer: the importance of being senescent | Q53663083 | ||
Tumour biology: Policing of oncogene activity by p53 | Q57562778 | ||
p19ARF links the tumour suppressor p53 to Ras | Q57562848 | ||
Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage | Q59081725 | ||
PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage | Q64387887 | ||
p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells | Q71618789 | ||
Protein phosphatase type 1, the product of the retinoblastoma susceptibility gene, and cell cycle control | Q77625348 | ||
Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia | Q81318088 | ||
Modeling the therapeutic efficacy of p53 restoration in tumors | Q34593294 | ||
The RB and p53 pathways in cancer | Q34804764 | ||
Decision making by p53: life, death and cancer | Q35116663 | ||
Analysis of p53-regulated gene expression patterns using oligonucleotide arrays | Q35191756 | ||
PML is induced by oncogenic ras and promotes premature senescence | Q35201220 | ||
Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation | Q35861554 | ||
Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation | Q35973184 | ||
Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. | Q36050995 | ||
The complexity of p53 stabilization and activation | Q36443523 | ||
Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy. | Q36547736 | ||
Oncogene-induced cell senescence--halting on the road to cancer | Q36587198 | ||
p53: guardian of the genome and policeman of the oncogenes. | Q36800812 | ||
Of mice without pockets: mouse models to study the function of Rb family proteins. | Q36814044 | ||
From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway | Q36989718 | ||
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor | Q37258978 | ||
Ultraviolet radiation, but not γ radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389 | Q37413761 | ||
Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage | Q39452086 | ||
Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model | Q39542680 | ||
Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene | Q39659874 | ||
Threshold level of p53 required for the induction of apoptosis in X-irradiated MOLT-4 cells | Q40125026 | ||
Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. | Q40933283 | ||
High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein | Q41127793 | ||
Temporal dissection of p53 function in vitro and in vivo | Q44365729 | ||
Constitutively active protein phosphatase 1alpha causes Rb-dependent G1 arrest in human cancer cells | Q46808819 | ||
Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts | Q47445812 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e3230 | |
P577 | publication date | 2008-09-18 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Characterization of the p53 response to oncogene-induced senescence | |
P478 | volume | 3 |
Q38506086 | ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas |
Q28397132 | Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead |
Q37763785 | Bypassing cellular senescence by genetic screening tools |
Q37828383 | Cellular senescence as a target in cancer control |
Q27026235 | Disruptive chemicals, senescence and immortality |
Q44627811 | Down-regulation of spinophilin in lung tumours contributes to tumourigenesis |
Q36562082 | Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA. |
Q33533301 | Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models |
Q37305035 | Genetic modelling of the PTEN/AKT pathway in cancer research |
Q47999229 | Genome-Wide miRNA Screening for Genes Bypassing Oncogene-Induced Senescence |
Q38072352 | Markers of Cellular Senescence |
Q27341883 | Modeling a New Water Channel That Allows SET9 to Dimethylate p53 |
Q46891284 | Modeling of cell culture damage and recovery leads to increased antibody and biomass productivity in CHO cell cultures |
Q50575186 | Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas |
Q42722283 | Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53. |
Q40066192 | Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa |
Q37362503 | Phosphorylation of gH2AX as a novel prognostic biomarker for laryngoesophageal dysfunction-free survival |
Q38236704 | Protein phosphatase 1 catalytic isoforms: specificity toward interacting proteins |
Q52715352 | The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest |
Q39739160 | The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway |
Q39408183 | p38α limits the contribution of MAP17 to cancer progression in breast tumors |
Search more.